T1	Limitation 29768 29769	A
T2	Limitation 32927 32937	Therefore,
T3	Limitation 24995 24997	We
T4	Population 24995 25039	We had hoped for a higher participation rate
T5	SampleSize 32938 32970	our sample size may be too small
T6	RelevantOutcomeExcluded 29817 30052	the IMR treatment integrity scale (IT-IS) to measure the therapeutic skills of the IMR-instructors or assessment to measure the implementation of IMR at organization level by the General organizational index (GOI-scale) was not applied
T7	Limitation 30068 30070	As
T8	Population 30121 30164	exposure to IMR was lower than we had hoped
T9	ExperimentalPhaseDuration 30919 31049	the waiting time from randomization to the first IMR group session was, on average, 87â€‰days, which might have affected the results
T10	Limitation 30906 30917	Furthermore
T11	Limitation 31293 31295	In
T12	Limitation 31749 31750	A
T13	HighLossToFollowUp 31825 31854	a high lost to follow-up rate
T14	NonstandardTreatmentCharacteristics 31410 31463	a spill-over effect in the control group was possible
T15	Limitation 31856 31867	Furthermore
T16	MissingData 31890 31993	nearly one-third of the participants did not complete the self-report instruments a long-term follow-up
